A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients

Clinical trial NCT00827112 · COMPLETED

Trial details

NCT number: NCT00827112
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Human Immunodeficiency Virus-1

Start date: 2009-03-01
Primary completion: 2010-07-01
Enrollment: 129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.